Skandinaviska Enskilda Banken (SEB)’s AstraZeneca AZN Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$42.9M	Buy	226,042 +3,964	+2%	+$746K	1.61%	16
2026 Q1	$43.8M	Buy	+222,078	New	+$42.8M	1.01%	17
2025 Q3	–	Sell	-41,237	Closed	-$5.76M	–	799
2025 Q2	$5.76M	Sell	41,237 -1,464	-3%	-$205K	0.03%	393
2025 Q1	$6.28M	Sell	42,701 -1,410	-3%	-$204K	0.03%	367
2024 Q4	$5.78M	Hold	44,111	–	–	0.03%	390
2024 Q3	$6.87M	Hold	44,111	–	–	0.03%	345
2024 Q2	$6.88M	Hold	44,111	–	–	0.03%	322
2024 Q1	$5.97M	Hold	44,111	–	–	0.03%	370
2023 Q4	$5.94M	Hold	44,111	–	–	0.03%	354
2023 Q3	$5.97M	Sell	44,111 -1,279	-3%	-$175K	0.04%	332
2023 Q2	$6.5M	Buy	45,390 +11,160	+33%	+$1.64M	0.04%	341
2023 Q1	$4.75M	Sell	34,230 -1,675	-5%	-$225K	0.03%	375
2022 Q4	$4.87M	Sell	35,905 -2,080	-5%	-$261K	0.04%	357
2022 Q3	$4.17M	Hold	37,985	–	–	0.03%	388
2022 Q2	$5.02M	Hold	37,985	–	–	0.04%	363
2022 Q1	$5.04M	Buy	37,985 +16,280	+75%	+$1.95M	0.03%	389
2021 Q4	$2.54M	Sell	21,705 -2,820	-11%	-$332K	0.01%	593
2021 Q3	$2.95M	Buy	24,525 +10,224	+71%	+$1.19M	0.02%	552
2021 Q2	$1.71M	Buy	+14,301	New	+$1.57M	0.01%	703

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s AZN Position: Q2 2026 in Review

Skandinaviska Enskilda Banken (SEB) increased its AstraZeneca (AZN) stake by 1.8% in Q2 2026, buying an estimated $746K and bringing the position to 226,042 shares worth $42.9M. The position accounts for 1.61% of the portfolio, ranked #16.

Skandinaviska Enskilda Banken (SEB) first reported a position in AZN in Q2 2021 and has held it in 19 quarters since. The position peaked at $43.8M in Q1 2026. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Skandinaviska Enskilda Banken (SEB) held 226,042 shares of AstraZeneca worth $42.9M as of Q2 2026.
Skandinaviska Enskilda Banken (SEB) bought 3,964 AstraZeneca shares in Q2 2026, an estimated $746K.
AstraZeneca made up 1.61% of Skandinaviska Enskilda Banken (SEB)'s portfolio in Q2 2026, its #16 holding.
Skandinaviska Enskilda Banken (SEB) first reported a position in AstraZeneca in Q2 2021 and has held it in 19 quarters since.
Skandinaviska Enskilda Banken (SEB)'s AstraZeneca position peaked at $43.8M in Q1 2026.
1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q2 2026, filed 10 Aug 2026.